Cost-effectiveness of the NIMH multisite HIV prevention intervention

被引:0
|
作者
Pinkerton S.D. [1 ]
Holtgrave D.R. [2 ]
Johnson-Masotti A.P. [1 ]
Turk M.E. [1 ]
Hackl K.L. [1 ]
DiFranceisco W. [1 ]
机构
[1] Center for AIDS Intervention Research, Department of Psychiatry and Behavioral Medicine, Medical College of Wisconsin, Milwaukee, WI
[2] Division of HIV/AIDS Prevention: Intervention Research and Support, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA
关键词
Cost-benefit; Cost-effectiveness; Economic analysis; Human immunodeficiency virus; Modeling; Prevention; Risk reduction;
D O I
10.1023/A:1014532713594
中图分类号
学科分类号
摘要
The objective of this study was to evaluate the cost-effectiveness of a state-of-the-art sexual-risk reduction intervention for high-risk men and women. The main intervention consisted of seven small-group sessions based on well-established principles of cognitive-behavioral therapy. This intervention was compared with a single-session video-based risk reduction intervention. The main outcome measure was the incremental cost-utility ratio, which equals the additional cost per additional quality-adjusted life year (QALY) saved by the cognitive-behavioral intervention, in comparison with the video intervention. A mathematical model of HIV transmission was used to translate reported sexual behavior changes into estimates of the number of HIV infections averted by the interventions, and associated savings in QALYs and averted HIV-related medical costs. For women, the incremental cost-utility ratio equaled $32,688 per QALY saved, which indicates that the cognitive-behavioral intervention was cost-effective compared to the video intervention. For men, the incremental cost-utility ratio was slightly negative, suggesting that the cognitive-behavioral intervention was highly cost-effective, or even cost-saving, compared to the video intervention. This analysis indicates that both brief and intensive sexual risk reduction interventions for high-risk populations can be cost-effective.
引用
收藏
页码:83 / 96
页数:13
相关论文
共 50 条
  • [41] Cost-effectiveness of PrEP for HIV Prevention among MSM: A systematic Review
    Damm, O.
    Scholz, S.
    Greiner, W.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2016, 14 : 15 - 15
  • [42] Cost-effectiveness of HIV prevention interventions in Andhra Pradesh state of India
    Dandona L.
    Kumar S.P.
    Kumar G.A.
    Dandona R.
    BMC Health Services Research, 10 (1)
  • [43] Endpoints and other measures in the NIMH Multisite HIV Prevention Trial: rationale and psychometric properties
    Fishbein, M
    Coutinho, R
    AIDS, 1997, 11 : S37 - S47
  • [45] The Cost and Cost-Effectiveness of an Integrated Wasting Prevention and Screening Intervention Package in Burkina Faso and Mali
    Brander, Rebecca L.
    Puett, Chloe
    Becquey, Elodie
    Leroy, Jef L.
    Ruel, Marie
    Sessou, Fidele Eric
    Huybregts, Lieven
    JOURNAL OF NUTRITION, 2024, 154 (08): : 2551 - 2565
  • [46] Cost-effectiveness analysis of a complementary health intervention: The case of smoking relapse prevention
    Chirikos, TN
    Herzog, TA
    Meade, CD
    Webb, MS
    Brandon, TH
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2004, 20 (04) : 475 - 480
  • [47] Assessment of the Cost-Effectiveness of a Brief Video Intervention for Sexually Transmitted Disease Prevention
    Williams, Austin M.
    Gift, Thomas L.
    O'Donnell, Lydia N.
    Rietmeijer, Cornelis A.
    Malotte, C. Kevin
    Margolis, Andrew D.
    Warner, Lee
    SEXUALLY TRANSMITTED DISEASES, 2020, 47 (02) : 130 - 135
  • [48] Cost-Effectiveness Considerations for Disease Intervention
    Williams, Austin M.
    Gift, Thomas L.
    SEXUALLY TRANSMITTED DISEASES, 2023, 50 (8S) : S28 - S30
  • [49] Discussion of "comparison of clinical and cost-effectiveness of 3 intervention strategies for HIV wasting"
    Hatoum, HT
    Walton, SM
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2005, 40 (02) : 236 - 237
  • [50] Cost-effectiveness of ximelagatran for stroke prevention
    Perret-Guillaume, C
    Wahl, D
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (23): : 2860 - 2861